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ess: drjayakrish@hotmaSummary Although factors influencing sputum smear conversion in tuberculosis
have been studied well, the effect of smoking is largely unknown. Excluding those
with incomplete history or drug resistant isolates, 339 patients out of the 526 sputum
positive patients registered between1998 and 2000 were studied. At the end of 2
months, smokers and non-smokers converted with almost the same frequency to a
negative sputum status {P ¼ 0:065; OR (95%CI) 0.47 (0.21–1.06)}. Although gender or
age had no effect on sputum conversion with respect to smoking status, expatriate
smokers as a whole showed a significant difference. (P ¼ 0:039). On applying logistic
regression model, smokers with far advanced radiographic abnormalities (Po0:038)
or with 3+ smear status (P ¼ 0:011), were found to have a less chance of an early
smear conversion. In conclusion smoking did not influence sputum smear conversion
in tuberculosis. However, as expatriate smokers and smokers with advanced disease
showed a delay in smear conversion, smoking should be discouraged in patients with
pulmonary tuberculosis.
& 2004 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
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.
il.com (B. Jayakrishnan).Introduction
There is a substantial variability in the response to
therapy for pulmonary tuberculosis (TB), even in
those patients with fully drug sensitive isolates.
The exact reason is not known but may be due to
variability in the mycobacterial and host biologiced.
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though very effective regimens are in use; high
cure rates are not often achieved in regular
practice. Recent reports of WHO show 78% cure
rates in countries that used directly observed short
course chemotherapy (DOTS) and 45% in those who
did not.2
Cigarette smoking is associated with differences
in the incidence, severity or natural history of a
broad array of respiratory illness like common cold,
pneumothorax, pulmonary hemorrhage and various
interstitial lung diseases, to name a few.3 Smoking
causes various pathophysiological changes in the
whole of respiratory tract ranging from local
anatomical destruction to complex immunological
effects.3 Therefore, naturally the lung defense
mechanisms against mycobacterium or its elimina-
tion should be affected. Smoking is a known risk
factor for tuberculosis skin reactivity, skin test
conversion and development of active tuberculo-
sis.4–7 Passive smoking was found to have a higher
risk for the development of active tuberculosis in
child contacts of an index case.8 Factors influencing
sputum smear conversion have been studied ex-
tensively, but the effect of smoking has not
been evaluated well.9–11 In the light of sparse
data, we decided to look into the direct effect of
cigarette smoking on smear conversion following
proper chemotherapy in patients with pulmonary
tuberculosis.Methods
As a general national policy of the State of Kuwait,
all sputum positive tuberculous patients are re-
ferred to the TB Control Unit from all over the
country. As far as possible they are admitted and
treated as in-patients till they become non-infec-
tious. Patients with sputum positive status at the
time of diagnosis, during a 3-year period from
January 1998 to December 2000 were enrolled in
the study. Basic data, smear and culture result at
presentation, smoking history, history of diabetes,
drug abuse and alcoholism were entered in a
profoma. The extent of the radiological lesions
were categorized and noted as minimal, moder-
ately advanced and far advanced as per the
classification of the National tuberculosis associa-
tion.12 Lesions were considered to be minimal if
they were of slight to moderate density without
cavitation and involved a part of one or both lungs,
the total extent being less than the volume of lung
on one side which was present above the second
chondrosternal junction. Moderately advanced le-sions were those which were present in one or both
lung but the total extent did not exceed the
following limits: disseminated lesions of slight to
moderate density which extended throughout the
total volume of one lung, or the equivalent in both
lungs; dense and confluent lesions which were
limited in extent to one-third the volume of one
lung; total diameter of cavitation, when present,
was less than 4 cm. Those lesions more extensive
than these were recorded as far advanced. Current
smokers were grouped as light and heavy smokers
according to the format adopted by Beck et al.13
Those smoking 20 or fewer cigarettes per day were
classified as light smokers and those smoking more
than 20 cigarettes a day as heavy smokers.
Early morning sputum was properly collected
from all patients. Smears were then prepared
directly from each sample and after concentration.
Staining for acid fast bacilli (AFB) was done by the
Zehil Neelson technique. All the above were done
by experienced technicians according to the stan-
dard procedures.14 Smears were reported as nega-
tive, 1+, 2+, and 3+ according to the American
thoracic society recommendations.15 Sputum ex-
aminations were repeated, whenever available, at
the end of second and fifth months of therapy. The
first sample and the sputum at the end of 2 months
of treatment were subjected to culture.
All these patients were given chemotherapy.
Majority of the patients received a 6-month regi-
men with rifampicin (R), isoniazid (H), ethambutol
(E) and pyrazinamide (Z) daily at standard doses for
2 months, followed by isoniazid and rifampicin daily
for another 4 months. A few patients received
other acceptable treatment regimens. Drug toxi-
city, opthalmological status, other organ damage,
drug interactions, etc. influenced the choice of the
alternate regimen.
The drug resistant strains do not respond to the
treatment with the usual regimens containing first
line anti-tuberculous drugs. Therefore, the smear
conversion is usually delayed and may not occur at
the end of 2 months. Hence, those patients with
drug resistant isolates were not included in the
study. Ex-smokers and those with incomplete
smoking history were also excluded from the
analysis. The current smokers and non-smokers
were prospectively followed up till they completed
treatment.
The data was then tabulated and analyzed using
the statistical package for social sciences program
(SPSS, PC Version 11.0). The various variables were
cross tabulated and the Chi-square test or Fischer’s
exact test were used to see if any association exist
or proportions were significantly different. Odds
ratio with their 95% confidence intervals are also
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out using sputum status as the binary-dependent
variable and the other variables as independents.Results
There were 526 patients with sputum positive
status for AFB by smear in this 3-year period, from
January 1998 to December 2000. 27 patients had
AFB resistant to one or more drugs. From the
remaining 499 patients, ex-smokers and smokers
with incomplete smoking history were excluded.
Sputum status at the end of two months and the
smoking history was known for 339 patients and this
formed the study population.
Two hundred and sixty-seven patients (78.8%)
were males and 72 (21.2%) were females. A vast
majority of these patients were expatriates
(82.6%), while Kuwaitis formed only 17.4%.
Although expatriate patients were of different
nationalities most of them were from India
(33.8%), Pakistan (7.8%), Bangladesh (12%), Philip-
pines (12%), Egypt (5.3%) and the other Arab
countries. One hundred and eighty-three patients
(54%) were smokers and 156 (46%) were non-
smokers. An equal distribution was noted among
light (49.1%) and heavy smokers (50.9%). As stated
all of them were sputum smear AFB positive at the
beginning of treatment, 71.4% having 1+, 18.9%
having 2+ and 9.7% having 3+ bacilli in the smear.
When all the 339 patients were considered
together, there was no statistically significant
difference (P ¼ 0:065) between the number of
smokers and non-smokers, who converted to a
negative sputum AFB status, 162(88.5%) and
147(94.2%), respectively, at the end of 2 months.
No difference was seen between light and heavy
smokers as well (P ¼ 0:901). Sputum conversion in
males and female smokers, nationals and expatri-
ate smokers and in different age groups was
compared separately. Although no significant dif-
ference was noticed in either gender or different
age groups, expatriate smokers as a whole showed
a statistically significant difference. (P ¼ 0:039).
Odds ratio, 95% confidence intervals and the ‘P’
values are presented in Table 1.
Serum albumin was low (o35g/l) in a significant
number of our patients with pulmonary tubercu-
losis. No significant difference was seen between
the number of smokers and non-smokers who
converted at the end of 2 months in patients with
either normal or low albumin. The same observa-
tion was seen in patients with a history of diabetes,
drug abuse and alcoholism. Since these are factorsdepressing one’s immunity and as the numbers in
each group were small they were combined to
improve the validity of Chi-square test. (Table 1).
The influence of disease factors like the extent of
radiological lesions, initial bacillary load and the
chemotherapy regimen on sputum conversion were
also analyzed in relation to smoking history. Only
66.7% of the smokers, where as 100% of non-
smokers with 3+ sputum status converted to a
negative smear giving a significant association, P ¼
0:027: Logistic regression analysis showed a sig-
nificant difference in the smear conversion seen in
smokers with far advanced radiological presenta-
tion when compared to the non-smokers in this
category (Table 2). This was not observed in the
initial analysis.Discussion
It has been long known that in tuberculosis, factors
like diet, rest, climate and accommodation have no
influence in the response to treatment which
depends mainly on the adequate chemotherapy,
severity of the disease and the regularity of drug
intake.9 In a recent report from New Jersey,
patients who received four or more drugs initially
showed a 36% more chance of early sputum culture
conversion. Those who were under the care of
specialized clinics also had a higher rate of culture
conversion. Sex, foreign-born status, homelessness,
drug abuse and infection with human immunodefi-
ciency virus (HIV) did not influence this.10 Telzak et
al. 11 found that cavitary disease, numerous AFB on
the initial smear and no prior history of tuberculosis
were associated with an increased number of days
for both sputum smear and culture conversion.
In this study, we found that smoking did not
influence the chances of an early sputum conver-
sion when other factors remained stable. This is in
contrast to the observations by Shprykov and
Zhadnov,16 a study reported in Russian language
but available as an abstract in Medline. This
observation remained true in male and female
smokers of our group, when considered separately.
The validity of this finding in female smokers
cannot be assured, as their numbers were very
small. Although the case rate of tuberculosis is
known to be more in males, gender inequalities
have not been studied well.7,18–19 In a study on
smoking in Kuwait, men were found to smoke more
number of cigarettes and they started this habit at
an earlier age.19–20 In our study, sputum conversion
at the end of 2 months occurred with the same
frequency among light and heavy smokers. So in
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Table 1 Smoking and smear status at the end of 2 months of chemotherapy in smokers and non-smokers as a
whole and in subgroups.
Smokers Non-smokers P-value OR (95% CI)
n* %y n* %y
All patients 183 88.5 156 94.2 0.065 0.472 (0.21–1.06)
Nationality
Kuwaiti 41 90.2 18 88.9 0.874 1.156 (0.19–6.97)
Non kuwaiti 142 88.0 138 96.9 0.039 0.393 (0.16–0.98)
Gender
Male 181 88.6 86 95.3 0.068 0.372 (0.12–1.12)
Female 2 100.0 65 92.9 0.865 0.420 (0.02–9.89)
Age
o24 7 85.7 7 100.0 0.500 0.289 (0.10–8.39)
25–44 56 87.5 22 90.9 0.507 0.700 (0.13–3.66)
45–64 100 88.0 98 93.9 0.150 0.478 (0.17-1.33)
4 65 20 95.0 28 96.4 0.665 0.704 (0.04–11.97)
Chest radiograph
Minimal 43 95.3 25 100.0 0.396 0.326 (0.15–7.06)
Moderate 86 90.7 88 95.5 0.216 0.464 (0.14–1.60)
Far advanced 49 77.6 37 86.5 0.292 0.540 (0.17–1.72)
Sputum status
+ 124 91.1 118 95.8 0.147 0.455 (0.15–1.35)
++ 38 92.1 26 84.6 0.290 2.121 (0.43–10.40)
+++ 21 66.7 12 100.0 0.027 0.077 (0.01–1.50)
Drug regimen
EHRZy 165 89.0 139 95.0 0.063 0.433 (0.18–1.07)
RHZy 6 100.0 5 80.0 0.455 4.333 (0.14–132.4)
SHERZy 8 75.0 8 100.0 0.233 0.153 (0.01–3.77)
Othersy 4 75.0 4 75.0 0.786 1.000(0.05 –24.57)
D/D/A groupz
Absent 109 90.8 106 96.2 0.109 0.388 (0.12–1.28)
Present 73 84.9 50 84.9 0.412 0.626 (0.20–1.93)
Albumin
Low 145 87.6 128 93.0 0.137 0.534 (0.23–1.23)
Normal 23 91.3 16 100.0 0.341 0.261 (0.01–5.81)
*Number tested.
yPercentage within the smoking status of the patient.
zDiabetes/drug abuse/alcoholism grouped together.
yRegimens used, see text. (E=ethambutol, H=INH, R=rifampicin, Z=pyrazinamide, S=streptomycin).
A.T. Abal et al.418general, number of cigarettes smoked or the sex
difference did not influence smear conversion.
Surprisingly, we noted that the expatriate smokers
had a less chance of smear conversion at the end of
2 months. This observation is important as the
majority of our patients (82.6%) belonged to this
group. No. data is available comparing the smoking
habits of different nationalities in this country.
Hence, we cannot attribute this change to the type
of cigarettes smoked or the duration of smoking.
The disease characteristics like smear and radi-ological status and the chemotherapy regimen were
also similar between the nationals and expatriates
and so would not have influenced this finding. Thus,
smoking did influence smear conversion in a group
with a large number of patients. Liu et al.10 found
that patients younger than 65 years were about two
times more likely to document sputum culture
conversion than the elderly. Young and the old in
our study group, whether they smoked or not, did
not show any difference in smear conversion at the
end of 2 months.
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Table 2 Logistic regression analysis of negative sputum status at the end of 2 months with different variables.
Variable Category Odds ratio 95% CI P-value
Age (years) o25 (Ref)
25–44 1.447 0.11–19.93 0.782
45–65 0.778 0.08–7.19 0.825
465 0.804 0.08–7.92 0.852
Gender Male 1.196 0.40–3.56 0.748
Female
Nationality Kuwaiti 1.381 0.48–4.00 0.552
Non-Kuwaiti
D/D/A Group* Present 0.445 0.19–1.06 0.068
Absent
Albumin Low 0.681 0.14–3.26 0.631
Normal
Chest radiograph Minimal (Ref)
Moderate 1.184 0.61–2.31 0.619
Advanced 0.390 0.21–0.76 0.006
Sputum + (Ref)
++ 1.167 0.60–2.27 0.648
+++ 0.445 0.22–0.89 0.022
*Diabetes/drug abuse/alcoholism grouped together.
Smoking and smear conversion in TB 419Karyadi et al. 21 found that generally TB patients
had a significantly poor micronutrient status when
compared to healthy controls. They also observed
that serum albumin was low in malnourished and
not in well-nourished TB patients. The mean serum
albumin concentration in our subjects (28.6 gm/l)
was well below normal. It is well known that
alcoholism, drug abuse and diabetes predispose to
tuberculosis and result in a poor response to
treatment.15,17,22–24 We did not find any significant
difference in the number of smokers and non-
smokers with different serum levels of albumin or
with a history of diabetes, drug abuse or alcoholism
who converted at the end of two months of
chemotherapy.
Cavitary disease and numerous AFB on smear are
well-recognized risk factors for lengthening the
time for sputum smear or culture conversion.11 We
found that greater the bacillary load lesser the
number of smokers who converted at the end of 2
months. This association was also observed in
patients with extensive disease noted on the chest
radiograph. So in patients with an extensive disease
either by microbiological or radiological standards,
smoking delayed smear conversion. Even though as
a whole smoking was not found to influence the
early response to treatment, our finding of this
delay in patients with an advanced disease seems
to be very much pertinent to the clinical practice.
This probably gives us enough evidence to advice
patients with pulmonary tuberculosis to stop
smoking.The role of good chemotherapy in tuberculosis
has been documented many times since the
discovery of Streptomycin decades ago. Ninety
percent of our patients were on EHRZ, 3.2% on
RHZ and 4.4% on SHERZ regimens, which are all
acceptable treatment protocols. When these pa-
tients were analyzed according to the chemother-
apy regimen, no change was seen between smokers
and non-smokers in each group. So we can see that
smoking independently did not influence the smear
conversion.
In conclusion, smoking did not generally prolong
the time for sputum smear conversion in patients
with active pulmonary tuberculosis. When other
factors were considered a high initial bacillary
load, far-advanced radiological lesions and the
expatriate status were found to delay the sputum
conversion in smokers. Because of this delay seen in
a major sub group of our patients and in all patients
with advanced disease, we recommend that
patients with pulmonary tuberculosis should be
encouraged to stop smoking while they are on
chemotherapy.References
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